Financials in USD. Standardized financial statements.
A compact view of how Daré Bioscience, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $1.03M | $9,784 | $2.81M | $10.00M | $0 | $0 | $0 | $0 | $0 | $766,000 |
| Revenue Growth? | +10429.4% | -99.7% | -71.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $2.45M | $14.31M | $21.64M | $30.14M | $100,000 | $83,333 | $11,137 | $625,000 | $0 | $400,000 |
| Gross Profit? | -$1.42M | -$14.30M | -$18.83M | -$20.14M | -$100,000 | -$83,333 | -$11,137 | -$2,440 | $0 | $366,000 |
| Gross Margin? | -137.5% | -146110.2% | -670.6% | -201.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | +47.8% |
| Operating Expenses? | $12.14M | $9.16M | $12.11M | $11.24M | $38.97M | $27.32M | $14.33M | $11.70M | $3.69M | $37.92M |
| Operating Income? | -$13.55M | -$23.45M | -$30.94M | -$31.39M | -$39.07M | -$27.40M | -$14.34M | -$16.88M | -$11.18M | -$37.15M |
| EBITDA? | -$11.40M | -$23.41M | -$30.70M | -$31.36M | -$39.04M | -$27.36M | -$14.25M | -$11.69M | -$11.18M | -$36.81M |
| Income Before Tax | -$13.40M | -$4.05M | -$30.16M | -$30.95M | -$38.70M | -$27.40M | -$14.26M | -$16.74M | -$11.50M | -$39.30M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10.23M | $0 | $86,000 |
| Net Income? | -$13.40M | -$4.05M | -$30.16M | -$30.95M | -$38.70M | -$27.40M | -$14.26M | -$16.74M | -$11.50M | -$39.30M |
| EPS? | $-1.20 | $-0.48 | $-4.15 | $-4.39 | $-7.52 | $-10.93 | $-10.99 | $-30.16 | $-3.56 | $-14.20 |
| Diluted EPS? | $-1.20 | $-0.48 | $-4.15 | $-4.39 | $-7.52 | $-10.93 | $-10.99 | $-30.16 | $-3.56 | $-30.02 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality